Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100048536Phase 4Not yet recruiting
Phase 4 trial of propofol and esketamine (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Sedation success rate and Incidence of adverse reactions. Planned start Jul 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100048536.